Back

18(a) Describe the mission/purpose of your proposed gTLD

gTLDFull Legal NameE-mail suffixDetail
.EXTRASPACEExtra Space Storage LLCmsn.comView
Extra Space Storage® Inc. (Extra Space) is a real estate investment trust based in Salt Lake City, Utah with regional offices in California, Connecticut, Florida, Maryland, Massachusetts, New Jersey, New York and Texas. Extra Space Storage is the second largest operator of self-storage in the U.S., and is a national owner, developer, acquirer and operator of professionally managed self-storage properties.
Extra Space Storage is a thirty year old company that has been involved in the self-storage industry since its inception. It is a growth-oriented company creating a new standard in the self-storage industry. Both customers and communities benefit from Extra Space Storageʹs professional approach to storage. Featuring attractive, convenient and secure facilities operated by professional managers, Extra Space Storage seeks to change the association of self-storage as a temporary holding place for rarely-used things to a desirable, safe, and customer-oriented facility perfectly suited for maintaining and accessing valued personal and business possessions.

Extra Space Storage Inc., headquartered in Salt Lake City, Utah, is a fully integrated, self-administered and self-managed real estate investment trust that owns and⁄or operates 870 self-storage properties in 34 states and Washington, D.C. The Companyʹs properties are comprised of approximately 550,000 units and over 59 million square feet of rentable space, offering customers a wide selection of conveniently located and secure storage solutions across the country, including boat storage, RV storage and business storage. The Company is the second largest owner and⁄or operator of self-storage properties in the United States and is the largest self-storage management company in the United States.

The preservation of this brand is of paramount importance to Extra Space in all aspects of its operations, including and especially on the Internet. Operating the brand as a gTLD will likely be an important part of its digital strategy in the future. Extra Space will be analyzing and evaluating other .BRAND gTLD applications as well as general market adoption to determine short and long-term potential best-in-class use case options to most effectively serve and enhance Extra Space’s online strategy as a leader in the self storage market.

The intended future mission and purpose of the .EXTRASPACE gTLD is to serve as a trusted, hierarchical, and intuitive namespace provided by Extra Space and its qualified affiliates, for Extra Space customers. Extra Space will be the entity to file this application and bring the .EXTRASPACE gTLD to market.

Although ICANN has not specifically recognized a .BRAND gTLD specification in the current round, it is widely anticipated in the brand community that this will become a specialty subset of gTLDs. .EXTRASPACE is intended to be one of those .BRAND gTLDs, with the goal of protecting Extra Space’s online presence and identity, expanding its marketing and promotion efforts, providing a secure channel for online products and services.

Extra Space intends to initially limit registration and use of domain names within the .EXTRASPACE gTLD to Extra Space and its qualified affiliates. This initial limited use will allow Extra Space to establish its operations and achieve full sustainability. This limited distribution coupled with the other requirements set forth in Specification 9 of the Template Registry Agreement is intended to exempt Extra Space from its annual Code of Conduct Compliance requirements.

Extra Space currently plans a three-stage rollout for Extra Space’s gTLD(s):

1. Stage One

The initial stage of implementation of the gTLD will involve Extra Space registering a limited number of .EXTRASPACE second-level domain names.

This initial use will provide Extra Space’s IT and security personnel the time to run a number of tests to ensure seamless and secure access using the .EXTRASPACE gTLD domain names, interoperability with various software and Web-based applications, and unbroken and secure use of all names. This initial allocation will also allow the appropriate Extra Space staff to coordinate with the internal and external staff responsible for the application, delegation and setup phases of the .EXTRASPACE gTLD to ensure a proper transition from delegation to full operation.

2. Stage Two

Once all testing has been successfully completed, Extra Space will begin allocating domain names in .EXTRASPACE for more widespread internal corporate use. During this same period of time, Extra Space will begin evaluating strategies to potential migrate traffic away from its existing second-level domain names.

It is in Stage Two that Extra Space will evaluate expanding the operations of the gTLD to permit registration by other registrants such as licensees or other strategic parties. Should an assessment of its expansion strategy lead to a decision to extend registration rights to other parties, this expansion is currently planned to take place during Stage Three. However, any expansion would be conditioned upon a review of the Specification 9 (Registry Code of Conduct) set forth in the template registry agreement to ensure compliance with Extra Space’s business model.

3. Stage Three

Depending upon the analysis of the evaluations undertaken in Stage Two, Extra Space may begin to implement the migration of Internet traffic away from Extra Space’s legacy domain names, and toward the Extra Space gTLD. It is in this stage that Extra Space also may implement its decision to extend registration rights to licensees or strategic parties, depending upon compliance with Specification 9 as noted above. The dates of such expansion are subject to change depending upon business, strategic, and industry factors at the time.

After consideration of the following factors: analysis of Extra Space’s existing domain name portfolio; internal analysis of marketing initiatives; and the fact that Extra Space will have full control over the number of registrations in the .EXTRASPACE gTLD namespace, Extra Space is confident that the number of domain name registrations will be less than 3,000 in the first five years of operation.

Based on its experience to the end of Year 5, and based on its experience with any expansion implemented in Stage Three, Extra Space will assess whether its business plan and any future expansion strategy. It is anticipated by Extra Space that changes to the domain name industry, and particularly the impact of .BRAND gTLDs, will take at least five years to be realized and assessed. Any decision to expand the gTLDs beyond corporate, qualified subsidiary and affiliate, and licensee use will take into account this experience as well as the technical analysis of potential expansion.

The potential use of the .EXTRASPACE gTLD by these or other business segments will also be driven by Extra Space’s future business strategies as identified in its annual report and investor filings.
gTLDFull Legal NameE-mail suffixDetail
.CIALISEli Lilly and Companyfairwindspartners.comView
Mission and Purpose of .CIALIS

Eli Lilly and Company (“Lilly”) is a leading global pharmaceutical company that produces medicines that help people live longer, healthier, and more active lives. Across the globe, Lilly has developed productive alliances and partnerships that advance its capacity to develop innovative medicines at lower costs. Lilly’s products are currently manufactured and distributed through facilities in the United States, Puerto Rico, and 11 other countries, and are sold in approximately 125 countries. The Cialis trademark has been registered by Lilly in over 125 countries. Lilly’s pharmaceutical products include, but are not limited to, neuroscience products, endocrinology products, oncology products, cardiovascular products, and animal health products. Lilly’s online content is accessible in the .COM gTLD and also in multiple ccTLDs, including .UK, .JP, .CA, and .NO.

The intended future mission and purpose of the .CIALIS gTLD is to serve as a trusted and intuitive namespace provided by Lilly and its qualified subsidiaries and affiliates for its consumers and the public. Eli Lilly and Company is the designated entity to file this application and bring the .CIALIS gTLD to market. However, Lilly is primarily filing this application in ICANN’s first gTLD application round for precautionary reasons given the uncertainty regarding when ICANN will be opening a second round. Therefore, although Lilly is committed to moving forward with the .CIALIS gTLD application, at the time of filing Lilly does not believe that there has been enough time or information available to fully analyze and evaluate all potential use case options.

Although ICANN has not specifically recognized a .BRAND gTLD specification in the Applicant Guidebook, it is widely anticipated within the brand-owner community that this will become a specialty subset of the new gTLDs. The .CIALIS gTLD is planned as a .BRAND gTLD, with the goal of protecting Lilly’s online presence and identity, providing a secure channel for online information and services, and offering a platform through which to potentially consolidate many of the online activities of Lilly related to its Cialis product.

Lilly intends to initially limit registration and use of domain names within the .CIALIS gTLD to Lilly and its qualified subsidiaries and affiliates. This initial limited use will allow Lilly to establish its operations and achieve full sustainability. This limited distribution coupled with the other requirements set forth in Specification 9 of the template Registry Agreement are intended to exempt Lilly from its annual Code of Conduct Compliance requirements.

After Stage 3 (see below), Lilly will evaluate whether opportunities exist to carry out the business strategy for the .CIALIS gTLD through expansion that continues the registry’s sustainable operations through registrations to parties other than Lilly and its qualified subsidiaries and affiliates.

Lilly currently plans for a four-stage rollout for the .CIALIS gTLD:

Stage 1: The initial stage of implementation of the gTLD will involve Lilly registering a limited number of .CIALIS second-level domain names.

This initial use will provide Lilly’s IT and security personnel an opportunity to run a number of tests to ensure seamless and secure access using the .CIALIS gTLD domain names, interoperability with various software and Web-based applications, and unbroken and secure use of all names. This initial allocation will also allow the appropriate Lilly staff to coordinate with the internal and external staff responsible for the delegation and setup phases of the .CIALIS gTLD to ensure a proper transition from delegation to full operation.

Stage 2: Once all testing has been successfully completed, Lilly will begin allocating domain names in .CIALIS for more widespread internal corporate use. During this same period of time, Lilly will begin evaluating strategies to potentially migrate Internet traffic related to Cialis away from its current patchwork network of second-level domain names, which are registered in a variety of TLDs, to the .CIALIS gTLD.

It is in Stage 2 that Lilly will evaluate expanding the operations of the gTLD to permit registration by other registrants such as approved partners. Should an assessment of its expansion strategy lead to a decision to extend registration rights to other parties, this expansion is currently planned to take place during Stage 3. However, any expansion would be conditioned upon a review of Specification 9 (Registry Code of Conduct) set forth in the template Registry Agreement to ensure compliance with Lilly’s business model.

Stage 3: Depending on the outcome of the evaluations undertaken in Stage 2, Lilly would subsequently implement an agreed-upon strategy to migrate Internet traffic related to Cialis away from the TLDs in which Lilly’s Cialis-related domain names are currently registered, and toward the .CIALIS gTLD. It is in this stage that Lilly also may implement its decision to expand registration rights to approved partners, conditioned upon compliance with Specification 9, as noted above. The dates of such expansion are subject to change depending upon business, strategic, and industry factors at the time.

After consideration of the following factors: analysis of Lilly’s existing domain name portfolio; internal analysis of marketing initiatives; and the fact that Lilly will have full control over the number of registrations in the .CIALIS gTLD namespace, Lilly believes that the number of domain name registrations will be less than 10,000 in the first five years of operation.

Stage 4: Based on its experience with any expansion implemented in Stage 3, Lilly will assess whether its business plan and expansion strategy should be augmented by extending registration rights to a broader class of approved partners. It is anticipated by Lilly that changes to the domain name industry, and particularly the impact of .BRAND gTLDs, will take at least five years from the date of delegation to be realized and assessed. Any decision to expand the gTLD beyond corporate, qualified subsidiary⁄affiliate, and approved partner use will take into account this experience as well as the technical analysis of potential expansion.

Furthermore, Lilly will be analyzing and evaluating other gTLD applications for comparable well-known trademarks and company names, as well as general market adoption, to determine short- and long-term potential strategies and options for the .CIALIS gTLD to more effectively serve and enhance Lilly’s online strategy as a leading global pharmaceutical company.

The potential use of the .CIALIS gTLD by Lilly and its various business segments will also be driven by Lilly’s future business strategies as identified in its annual report and public financial information, see for example: http:⁄⁄investor.lilly.com⁄financials.cfm.

After consideration of the following factors: analysis of Lilly’s existing domain name portfolio; internal analysis of online initiatives; the anticipated limited number of approved partners who would be granted a .CIALIS registration; and the fact that Lilly will have full control over the number of registrations in the .CIALIS gTLD namespace, Lilly believes that the number of domain name registrations will be less than 10,000 in the first five years of operation.

Utilizing current projections based upon Lilly’s existing businesses, future business plans, current domain name portfolio, and other strategic factors, Lilly estimates that second-level domain name registrations will be in line with the projections set forth in the financial template provided in response to Question 46 of this application.